No abstract available
MeSH terms
-
Costs and Cost Analysis
-
Graft Rejection / economics
-
Graft Rejection / therapy*
-
Humans
-
Illinois
-
Immunosuppressive Agents / economics*
-
Immunosuppressive Agents / therapeutic use
-
Length of Stay / economics
-
Muromonab-CD3 / economics*
-
Muromonab-CD3 / therapeutic use
-
Tacrolimus / economics*
-
Tacrolimus / therapeutic use
Substances
-
Immunosuppressive Agents
-
Muromonab-CD3
-
Tacrolimus